Development and validation of the Japanese version of the Hyperarousal Scale.
Depression
Hyperarousal
Hyperarousal scale
Insomnia
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
19 09 2022
19 09 2022
Historique:
received:
20
07
2021
accepted:
29
08
2022
entrez:
19
9
2022
pubmed:
20
9
2022
medline:
23
9
2022
Statut:
epublish
Résumé
The objectives of this study were to develop a Japanese version of the Hyperarousal Scale (HAS-J) and investigate its factor structure, reliability, and validity, as well as to calculate a cutoff score for the HAS-J and assess different levels of hyperarousal in insomnia patients and community dwellers. We recruited 224 outpatients receiving insomnia treatment (56.3% women; mean age 51.7 ± 15.6 years) and 303 community dwellers aged 20 years or older (57.8% women; mean age 43.9 ± 15.2 years). Exploratory and confirmatory factor analysis was performed to examine the factor structure of the HAS-J. Cronbach's α and McDonald's ω were then used to test internal consistency. To examine the scale's validity, we determined correlations between the HAS-J and other indexes and compared HAS-J scores between insomnia patients and community dwellers. We also compared HAS-J scores between two community-dweller groups (normal and poor sleepers) and two insomnia patient groups (with and without alleviation after treatment). Following exploratory and confirmatory factor analysis, a 20-item measure emerged comprising three factors: "Introspectiveness and Reactivity," "Neuroticism," and "Insomnia." Confirmatory factor analysis showed a generally good fit for the model of the three-factor structure suggested by the exploratory factor analysis loadings (χ This study demonstrated the reliability and validity of the HAS-J, indicating that it is useful as a clinical scale of hyperarousal. The high level of hyperarousal in insomnia patients who were assessed to be in remission by the Insomnia Severity Index suggests a risk of insomnia recurrence in these patients.
Sections du résumé
BACKGROUND
The objectives of this study were to develop a Japanese version of the Hyperarousal Scale (HAS-J) and investigate its factor structure, reliability, and validity, as well as to calculate a cutoff score for the HAS-J and assess different levels of hyperarousal in insomnia patients and community dwellers.
METHODS
We recruited 224 outpatients receiving insomnia treatment (56.3% women; mean age 51.7 ± 15.6 years) and 303 community dwellers aged 20 years or older (57.8% women; mean age 43.9 ± 15.2 years). Exploratory and confirmatory factor analysis was performed to examine the factor structure of the HAS-J. Cronbach's α and McDonald's ω were then used to test internal consistency. To examine the scale's validity, we determined correlations between the HAS-J and other indexes and compared HAS-J scores between insomnia patients and community dwellers. We also compared HAS-J scores between two community-dweller groups (normal and poor sleepers) and two insomnia patient groups (with and without alleviation after treatment).
RESULTS
Following exploratory and confirmatory factor analysis, a 20-item measure emerged comprising three factors: "Introspectiveness and Reactivity," "Neuroticism," and "Insomnia." Confirmatory factor analysis showed a generally good fit for the model of the three-factor structure suggested by the exploratory factor analysis loadings (χ
CONCLUSIONS
This study demonstrated the reliability and validity of the HAS-J, indicating that it is useful as a clinical scale of hyperarousal. The high level of hyperarousal in insomnia patients who were assessed to be in remission by the Insomnia Severity Index suggests a risk of insomnia recurrence in these patients.
Identifiants
pubmed: 36123639
doi: 10.1186/s12888-022-04243-0
pii: 10.1186/s12888-022-04243-0
pmc: PMC9484233
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
617Informations de copyright
© 2022. The Author(s).
Références
Can J Psychiatry. 2011 Sep;56(9):540-8
pubmed: 21959029
Psychosom Med. 2000 Jul-Aug;62(4):474-82
pubmed: 10949091
Sleep Med. 2010 May;11(5):452-7
pubmed: 20381419
Psychosom Med. 2004 Nov-Dec;66(6):925-31
pubmed: 15564359
Psychiatr Danub. 2012 Sep;24 Suppl 1:S51-5
pubmed: 22945187
Sleep. 2004 Mar 15;27(2):285-91
pubmed: 15124724
BMJ. 1997 Feb 22;314(7080):572
pubmed: 9055718
Sleep. 2000 May 1;23(3):415-6
pubmed: 10811386
J Appl Psychol. 2003 Oct;88(5):879-903
pubmed: 14516251
Am J Psychiatry. 2004 Nov;161(11):2126-8
pubmed: 15514418
J Affect Disord. 2003 Sep;76(1-3):255-9
pubmed: 12943956
Psychiatry Clin Neurosci. 2013 Sep;67(6):420-5
pubmed: 23910517
Diabetologia. 2005 Feb;48(2):235-41
pubmed: 15645205
Sleep. 2008 Apr;31(4):481-8
pubmed: 18457235
Am J Psychiatry. 1993 Oct;150(10):1529-34
pubmed: 8379559
Scand J Caring Sci. 2006 Mar;20(1):58-67
pubmed: 16489961
J Psychosom Res. 2001 Aug;51(2):435-41
pubmed: 11516766
Sleep. 2004 Nov 1;27(7):1369-77
pubmed: 15586790
Sleep Med. 2012 Jan;13(1):43-51
pubmed: 22093806
Sleep. 2000 Feb 1;23(1):41-7
pubmed: 10678464
Front Psychol. 2016 May 26;7:769
pubmed: 27303333
J Clin Sleep Med. 2014 Sep 15;10(9):1039-40
pubmed: 25221449
Sleep Med Rev. 2010 Feb;14(1):69-82
pubmed: 19962922
Sleep. 2011 May 01;34(5):601-8
pubmed: 21532953
J Adv Nurs. 2002 Mar;37(5):414-22
pubmed: 11843979
JAMA. 2013 Feb 20;309(7):706-16
pubmed: 23423416
Psychosomatics. 2001 Jan-Feb;42(1):29-34
pubmed: 11161118
J Psychosom Res. 2000 Jun;48(6):555-60
pubmed: 11033374
Int J Environ Res Public Health. 2020 Feb 12;17(4):
pubmed: 32059606
Thorax. 2004 Jul;59(7):618-22
pubmed: 15223874
Arch Gen Psychiatry. 1976 Sep;33(9):1128-24
pubmed: 962495
J Environ Public Health. 2011;2011:964617
pubmed: 22220186
Sleep. 1995 Sep;18(7):581-8
pubmed: 8552929
Menopause. 2004 Mar-Apr;11(2):198-207
pubmed: 15021450
Sleep Med. 2014 Feb;15(2):196-202
pubmed: 24380783
Sleep Med Rev. 2010 Feb;14(1):9-15
pubmed: 19640748
J Affect Disord. 2011 Dec;135(1-3):10-9
pubmed: 21300408
Sleep. 2010 Feb;33(2):177-84
pubmed: 20175401
Psychosom Med. 2000 Mar-Apr;62(2):227-30
pubmed: 10772402
Sleep Med Rev. 2010 Feb;14(1):19-31
pubmed: 19481481
Am J Psychiatry. 2008 Jun;165(6):678-86
pubmed: 18519533